- Global Pharma News & Resources

Human Microbiome Market Size, Share, Growth, Technology Trend, Current Status By Major Key Vendors | Global Industry Grow At A Cagr Of 18.9 % – 2027

Coherent Market Insights released a new market study on 2021-2027 Human Microbiome Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for 2021-2027 Human Microbiome Market Forecast till 2027*.

Request Here For Market Latest Insights:

Market Overview:

The human microbiota (the various microbial communities constantly living in the body) is now one of the largest researched areas in clinical biology. There are many interesting areas of study in this field, all of which have great importance to helping us understand and ultimately control some of the common diseases that plague our society today such as diabetes, obesity, heart disease, and more. The human intestinal tract is home to several hundred thousand microbial species. Together these bacteria form a community that is tightly connected to the immune system of the body and very closely associates with the DNA of each patient. The study of the human microbiota aid in the prevention of Crohn’s disease and ulcerative colitis condition.

Competitive Landscape:

Enterome SA, Igen Biolab Group, Evelo Biosciences Inc., Embion Technologies S.A, Ferring Pharmaceuticals, Gnubiotics Sciences, 4D Pharma Plc., YSOPIA Bioscience, Second Genome Therapeutics, Osel Inc., OxThera AB, ViThera Pharmaceuticals Inc., Immuron Ltd., AOBiome, Rebiotix Inc., Seres Therapeutics, Inc., Vedanta Biosciences, Inc., Assembly Biosciences, Inc., and Finch Therapeutics Group, Inc.

Market Drivers:

Growing research & development activities by key players in order to get a better understanding of microbes on human health is augmenting growth of the Human Microbiome Market. For instance, in November 2019, Nestlé has entered into a partnership with the University of California San Diego Center for Microbiome Innovation (CMI) to increase the understanding of the microbiome’s impact on human health and to accelerate the development of innovative nutritional solutions.

The increasing focus of key manufacturers to launch new and innovative medical food products is uplifting growth of the market. For instance, in June 2019, Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, has launched the first end-to-end sample prep kit on the market at the upcoming ASM Microbe 2019 event.

COVID-19 Analysis:

The market of human microbiome market was negatively impacted during the spread of COVID-19 infections. It has severely affected the entire supply chain of the medical food industry due to social distancing norms and lockdown. However, later on, the market has seen positive growth as COVID-19 directly affects the immune system and the use of probiotics improves immunity. This has defiantly raised the demand for probiotics during COVID-19 times.

Key Takeaway:

  1. North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of inflammatory bowel disease in the region. According to the Centers for Disease Control and Prevention’s, Inflammatory Bowel Disease (IBD) in the United States. About 1 percent of the U.S., or 3 million people, live with inflammatory bowel disease (IBD). People are most often diagnosed with Crohn’s disease or ulcerative colitis between ages 15 and 30
  2. The human microbiome market is expected to exhibit a CAGR of XX % over the forecast period, owing to the growing adoption of growth strategies such as mergers &acquasition among key players. For instance, in December 2020, Novozymes has acquired Microbiome Labs. Based in Illinois, US. Microbiome Labs offers a comprehensive portfolio of proprietary probiotic and microbiome solutions and is a vital player in the consumer health industry.

Purchase this Report at Discount Of US $2000 Flat OFF –

Reasons to Purchase this Report

• Current and future of global Human Microbiome Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players

Major Point Answered in Human Microbiome Market Research Study are:

  • What will be the progress rate of the Human Microbiome Market for the conjecture period, 2021-2027?
  • What are the prominent factors driving the Human Microbiome Market across different regions?
  • Who are the major vendors dominating the Human Microbiome industry and what are their winning strategies?
  • What will be the market scope for the estimated period?
  • What are the major trends shaping the expansion of the industry in the coming years?
  • What are the challenges faced by the Human Microbiome Market?

Request Here Sample Report @

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 23-Sep-2021